 I. To determine the optimal dose of CYT107. II. To evaluate the effect of concurrent dexamethasone. III. To evaluate the duration of effect on CD4 counts up to 6 months. IV. To evaluate the total lymphocyte counts over time and serial lymphocyte subtypes up to 6 months. 